ATE240116T1 - Verwendung von human-beta-interferon zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von chronischer myeloidleukämie - Google Patents

Verwendung von human-beta-interferon zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von chronischer myeloidleukämie

Info

Publication number
ATE240116T1
ATE240116T1 AT94112221T AT94112221T ATE240116T1 AT E240116 T1 ATE240116 T1 AT E240116T1 AT 94112221 T AT94112221 T AT 94112221T AT 94112221 T AT94112221 T AT 94112221T AT E240116 T1 ATE240116 T1 AT E240116T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
myeloidleukemia
chronic
treatment
production
Prior art date
Application number
AT94112221T
Other languages
English (en)
Inventor
Rita Michalevicz
Original Assignee
Interpharm Lab Ltd
Univ Ramot
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interpharm Lab Ltd, Univ Ramot filed Critical Interpharm Lab Ltd
Application granted granted Critical
Publication of ATE240116T1 publication Critical patent/ATE240116T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT94112221T 1989-03-19 1990-03-15 Verwendung von human-beta-interferon zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von chronischer myeloidleukämie ATE240116T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL89662A IL89662A (en) 1989-03-19 1989-03-19 Pharmaceutical compositions comprising interferon-beta

Publications (1)

Publication Number Publication Date
ATE240116T1 true ATE240116T1 (de) 2003-05-15

Family

ID=11059803

Family Applications (2)

Application Number Title Priority Date Filing Date
AT90104936T ATE157544T1 (de) 1989-03-19 1990-03-15 Verwendung von human-beta-interferon zur stimulierung der erythropoiesis
AT94112221T ATE240116T1 (de) 1989-03-19 1990-03-15 Verwendung von human-beta-interferon zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von chronischer myeloidleukämie

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT90104936T ATE157544T1 (de) 1989-03-19 1990-03-15 Verwendung von human-beta-interferon zur stimulierung der erythropoiesis

Country Status (12)

Country Link
US (1) US5104653A (de)
EP (2) EP0643973B1 (de)
JP (1) JP2883669B2 (de)
AT (2) ATE157544T1 (de)
AU (1) AU619960B2 (de)
CA (1) CA2011992C (de)
DE (2) DE69034076T2 (de)
DK (2) DK0388799T3 (de)
ES (2) ES2107414T3 (de)
GR (1) GR3024763T3 (de)
IL (1) IL89662A (de)
ZA (1) ZA901994B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4128319A1 (de) * 1991-08-27 1993-03-04 Bioferon Biochem Substanz Neues rekombinantes human-ifn-beta, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zubereitungen
US6242417B1 (en) 1994-03-08 2001-06-05 Somatogen, Inc. Stabilized compositions containing hemoglobin
US5631219A (en) * 1994-03-08 1997-05-20 Somatogen, Inc. Method of stimulating hematopoiesis with hemoglobin
EP1416282A3 (de) * 1995-07-25 2004-06-23 Toray Industries, Inc. Verfahren zur Identifizierung von Zusammensetzungen verwendbar in der Therapie von Knochenkrankheiten
WO1999040106A2 (en) * 1998-02-09 1999-08-12 University Of Southern California Use of angiotensin analogues for promoting erythropoiesis
DE10020129C1 (de) * 2000-04-14 2001-11-15 Siemens Ag Baugruppe mit Überspannungsableiter für eine Hochspannungsanlage
WO2002038170A2 (en) * 2000-11-07 2002-05-16 Chiron Corporation Stabilized inteferon compositions
US7405076B2 (en) * 2000-11-14 2008-07-29 Universite Libre De Bruxelles Generation and use of dendritic cells
US7176278B2 (en) 2001-08-30 2007-02-13 Biorexis Technology, Inc. Modified transferrin fusion proteins
US8084424B2 (en) * 2003-04-09 2011-12-27 University Of Utah Research Foundation Compositions and methods related to erythropoietin
US8778880B2 (en) 2004-02-02 2014-07-15 Ambrx, Inc. Human growth hormone modified at position 35
US20070191377A1 (en) * 2004-03-31 2007-08-16 Nitromed, Inc. Methods for treating blood disorders with nitric oxide donor compounds
WO2007097951A2 (en) * 2006-02-17 2007-08-30 Nitromed, Inc. Methods using hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460574A (en) * 1980-06-16 1984-07-17 Yabrov Alexander A Prophylaxis or treatment of interferon-sensitive diseases
GB8412564D0 (en) * 1984-05-17 1984-06-20 Searle & Co Structure and properties
CA1294215C (en) * 1986-10-27 1992-01-14 Ze'ev Shaked Pharmaceutical compositions of recombinant beta-interferon and formulation processes
US4851219A (en) * 1986-11-18 1989-07-25 Genentech, Inc. Method for the treatment of chronic myelogenous leukemia
AU2855189A (en) * 1988-01-25 1989-07-27 Baker Cummins Dermatologicals, Inc. Method of treating fibrotic disorders

Also Published As

Publication number Publication date
DE69031355D1 (de) 1997-10-09
DE69034076D1 (de) 2003-06-18
JP2883669B2 (ja) 1999-04-19
ZA901994B (en) 1990-12-28
DK0643973T3 (da) 2003-09-08
DE69034076T2 (de) 2003-11-20
DE69031355T2 (de) 1998-01-08
JPH0314523A (ja) 1991-01-23
IL89662A (en) 1997-11-20
EP0643973A1 (de) 1995-03-22
IL89662A0 (en) 1989-09-28
AU619960B2 (en) 1992-02-06
ES2107414T3 (es) 1997-12-01
EP0643973B1 (de) 2003-05-14
ATE157544T1 (de) 1997-09-15
GR3024763T3 (en) 1997-12-31
CA2011992C (en) 2003-04-29
EP0388799A3 (de) 1991-07-31
EP0388799B1 (de) 1997-09-03
EP0388799A2 (de) 1990-09-26
DK0388799T3 (da) 1998-03-30
AU5144590A (en) 1990-09-20
ES2198409T3 (es) 2004-02-01
CA2011992A1 (en) 1990-09-19
US5104653A (en) 1992-04-14

Similar Documents

Publication Publication Date Title
SG52690A1 (en) Process for the production of biologically active protein (e.g. tgf)
ZA848369B (en) Pharmaceutical compositions containing bilobalid for the treatment of neuropathies
ATE135363T1 (de) Nucleoside zur verwendung für die therapie
DE59000270D1 (de) Verwendung von mindestens ein cytokin zur herstellung eines arzneimittels zur systemischen behandlung von praeneoplastischen laesionen.
DE3752112D1 (de) Verwendung von Inositoltriphosphat zur Behandlung von Entzündungen
ATE240116T1 (de) Verwendung von human-beta-interferon zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von chronischer myeloidleukämie
GR3025488T3 (en) Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions
DE3584560D1 (de) Arzneimittelzusammensetzung geeignet zur behandlung oder prophylaxe von herzstoerungen.
ATE174798T1 (de) Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
ATE59780T1 (de) Pharmazeutische zusammensetzung zur behandlung von tumoren.
ATE114468T1 (de) Ethyl-(+)-apovincaminat zur behandlung der demyelinisierung klinischer erscheinungen autoimmunen ursprungs.
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
ATE247474T1 (de) Verwendung von inosittriphosphat zur herstellung von arzneimitteln
NO873934D0 (no) Fremgangsmaate for forbedret saarheling.
EP0248583A3 (en) Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
ATE130194T1 (de) Subkutane verabreichung des humanen choriongonadotropins.
IT1241927B (it) 3'-deamino-4'-deossi-4'-amino-8-fluoroantra- cicline processi per la loro preparazione e composizioni farmaceutiche che le contengono
GR3004272T3 (de)
HUT60145A (en) Process for producing pharmaceutical composition comprising human interleukin-2 and suitable for treating pneumothorax
DE69118847D1 (de) Verwendung von Heptastigmin zur Behandlung der zerebralen Ictus
ATE76571T1 (de) Zusammensetzung zur behandlung der haut.
ATE56360T1 (de) Zusammensetzung zur herstellung eines arzneimittels zur therapeutischen behandlung von hauttrauma.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0643973

Country of ref document: EP

EELA Cancelled due to lapse of time